Literature DB >> 22890671

Matricellular protein: a new player in cerebral vasospasm following subarachnoid hemorrhage.

Hidenori Suzuki1, Masato Shiba, Masashi Fujimoto, Kengo Kawamura, Mai Nanpei, Eriko Tekeuchi, Satoshi Matsushima, Kenji Kanamaru, Kyoko Imanaka-Yoshida, Toshimichi Yoshida, Waro Taki.   

Abstract

INTRODUCTION: Matricellular protein (MCP) is a class of nonstructural and secreted extracellular matrix proteins that exert diverse functions, but its role in vascular smooth muscle contraction has not been investigated.
MATERIAL AND METHODS: First, rat subarachnoid hemorrhage (SAH) models were produced by endovascular perforation and examined for tenascin-C (TNC) and osteopontin (OPN) induction (representatives of MCPs) in vasospastic cerebral arteries using immunostaining. Second, recombinant TNC (r-TNC), recombinant OPN (r-OPN), or both were injected into a cisterna magna in healthy rats, and the effects on the diameter of basilar arteries were determined using India ink angiography.
RESULTS: In SAH rats, TNC immunoreactivity was markedly induced in the smooth muscle cell layers of spastic cerebral arteries on day 1 but not in control animals. The TNC immunoreactivity decreased on day 3 as vasospasm improved: OPN immunoreactivity, on the other hand, was more induced in the arterial wall on day 3. r-TNC injections caused prolonged contractions of rat basilar arteries, which were reversed by r-OPN, although r-OPN itself had no effect on the vessel diameter.
CONCLUSIONS: MCPs, including TNC and OPN, may contribute to the pathophysiology of cerebral vasospasm and provide a novel therapeutic approach against it.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22890671     DOI: 10.1007/978-3-7091-1192-5_39

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  7 in total

1.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

2.  Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Yoshinari Nakatsuka; Masato Shiba; Hirofumi Nishikawa; Mio Terashima; Fumihiro Kawakita; Masashi Fujimoto; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2018-01-20       Impact factor: 5.590

Review 3.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

Review 4.  Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system.

Authors:  Kyoko Imanaka-Yoshida; Hiroki Aoki
Journal:  Front Physiol       Date:  2014-07-29       Impact factor: 4.566

Review 5.  The Role of Tenascin-C in Tissue Injury and Repair After Stroke.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

6.  Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Mari Hara; Hiromitsu Saito; Noboru Suzuki; Satoshi Sakai; Taizo Kimura; Akira Sato; Akiyo Sekimoto; Satoshi Fujita; Ryuji Okamoto; Robert J Schwartz; Toshimichi Yoshida; Kyoko Imanaka-Yoshida
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 7.  Osteopontin as a candidate of therapeutic application for the acute brain injury.

Authors:  Yunxiang Zhou; Yihan Yao; Lesang Sheng; Jianmin Zhang; John H Zhang; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-07-13       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.